Skip to content

Study on the Optimal Aspiration and Infusion Cycle Method for Blood Sampling via PICC in Patients with Hematological Malignancies

Application of an Optimal Push-Pull Protocol for Intracatheter Blood Sampling in Hematological Malignancy Patients Based on PICC Internal Volume

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600126460
Enrollment
Unknown
Registered
2026-06-09
Start date
2026-06-10
Completion date
Unknown
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematological diseases (including leukemia, lymphoma, anemia, and coagulation disorders) require long-term chemotherapy and frequent blood sampling. As the primary vascular access, PICC currently lacks standardized blood sampling protocols based on internal volume, and repeated push-pull manipulations may cause hemolysis, catheter occlusion, and infection. This study aims to measure

Interventions

Four-cycle push-pull blood sampling via PICC:Simplified push-pull cycle count
Blood sampling using the push-pull technique with 2 aspirations:Blood sampling using the push-pull technique with 2 aspirations

Sponsors

Zhenjiang First People's Hospital (Affiliated People’s Hospital of Jiangsu University)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Hospitalized hematology patients aged >=18 years who meet the diagnostic criteria for hematologic malignancies according to the *Chinese Society of Clinical Oncology (CSCO) Guidelines for the Diagnosis and Treatment of Malignant Hematological Diseases (2024)*, with a single-lumen 4Fr PICC catheter inserted via the right upper extremity, and with physician orders for routine blood tests; 2. PICC catheter with intact function, demonstrating adequate blood return and unobstructed infusion; 3. Absence of PICC-related complications (e.g., infection, thrombosis); 4. Catheter tip positioned at the lower one-third of the superior vena cava or at the junction of the superior vena cava and right atrium, as confirmed by imaging; 5. Voluntary participation in this study with signed informed consent; 6.Morning blood samples collected.

Exclusion criteria

Exclusion criteria: 1.Patients with hypercoagulable status; 2. Patients currently participating in other clinical studies that may interfere with the results of this study; 3. Patients receiving infusion or blood transfusion at the time of blood sampling.

Design outcomes

Primary

MeasureTime frame
Key Indices in Complete Blood Count:White blood cell count, neutrophil count, red blood cell count, hemoglobin count, platelet count;

Secondary

MeasureTime frame
Time spent on specimen collection;Catheter occlusion rate;

Countries

China

Contacts

Public ContactYuling Feng

Zhenjiang First People's Hospital (Affiliated People’s Hospital of Jiangsu University)

1713213093@qq.com+86 511 88915039

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 21, 2026